
Join to view full profile
61 Hawthorne AveHamden, CT 06517
Phone+1 203-506-4400
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 3 invites waiting! - Read the latest clinical news, personalized to your specialty.
Publications & Presentations
PubMed
- 48 citationsRuxolitinib Therapy Followed by Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation for Myelofibrosis: Myeloproliferative Disorders Research Consorti...Vikas Gupta, Heidi E. Kosiorek, Adam J. Mead, Rebecca B. Klisovic, John P. Galvin
Biology of Blood and Marrow Transplantation. 2019-02-01 - 14 citationsPhase II trial of Lestaurtinib, a JAK2 inhibitor, in patients with myelofibrosisJohn Mascarenhas, Maria R. Baer, Craig M. Kessler, Elizabeth O. Hexner, Douglas Tremblay
Leukemia & Lymphoma. 2019-01-22 - 52 citationsSafety and efficacy of combined ruxolitinib and decitabine in accelerated and blast-phase myeloproliferative neoplasms.Raajit K. Rampal, John Mascarenhas, Heidi E. Kosiorek, Leah Price, Dmitriy Berenzon
Blood Advances. 2018-12-26









